期刊文献+

内皮素受体拮抗剂抑制异丙肾上腺素诱导大鼠心肌细胞搏动加速及凋亡

Endothelin Receptor Antagonist CPU0213 Inhibits Cardiomyocytes Beat Accelerating and Apoptosis in Adult Rat Cardiac Myocytes Induced by Isoprenaline
下载PDF
导出
摘要 观察内皮素受体拮抗剂CPU0213能否阻断异丙肾上腺素(isoprenaline,ISO)所致大鼠心肌细胞搏动加速及凋亡。分离大鼠心肌细胞。给ISO(10-7M)的同时给CPU0213(10-7、10-6、10-5M),并以普萘洛尔(10-6M)作为阳性药对照,观察各组心肌细胞的搏动次数。采用吖啶橙/碘化丙啶(AO/PI)染色法检测成年大鼠心肌细胞凋亡率的变化。普萘洛尔明显抑制ISO效应(P<0.001)。内皮素受体拮抗剂CPU0213明显抑制ISO所致的心肌细胞搏动和细胞凋亡,且呈浓度依赖性。大剂量CPU0213对ISO生物效应的阻断作用(P<0.001)与普萘洛尔相仿。内皮素受体拮抗剂CPU0213阻断ISO所致的心肌细胞搏动加速和增加细胞凋亡率等生物学效应,提示内皮素介导β-受体效应。 To investigate whether CPU 0213 could inhibit adult cardiac myocytes beats accelerating and apoptosis induced by isoprenaline. Add isoprenaline (ISO, 107M) and CPU 0213 (10^-7. 10^-6. 10^-5M) in the same pore simultaneously, respectively. Propranolol (10^-6 M) was used as a positive control. We counted cardiomyocytes beats within lmin and the ratio of apoptosis in cultured adult rat cardiac myocytes using AO/PI fluorescent dye. ISO increased cardiomyocytes beat and rate of apoptosis significantly, Propranolol was effective to suppress the biological effects of ISO. CPU 0213 could inhibit cardiomyocytes beats accelerating and apoptosis induced by ISO in a dose dependent manner. Endothelin receptor antagonist CPU0213 inhibits apoptosis and Other biological effects in adult rat cardiac myocytes induced by ISO. Endothelin may mediate biological effects of -receptor activation.
出处 《中国药事》 CAS 2007年第11期874-877,共4页 Chinese Pharmaceutical Affairs
基金 国家自然科学基金资助项目 No.30572193
关键词 异丙肾上腺素 CPU0213 内皮素受体拮抗剂 吖啶橙/碘化丙啶(AO/PI)染色 心肌细胞 isoprenaline CPU0213 endothelin receptor antagonist AO/PI cardiac myocytes
  • 相关文献

二级参考文献32

  • 1戴德哉,吉民,黄敏,刘立钢.内皮素受体拮抗剂CPU0213的生物活性及抑制ETA及ETB受体的作用(英文)[J].中国药科大学学报,2004,35(6):552-557. 被引量:10
  • 2梁黔生(Liang QS).左心肥厚的研究近况[J].心血管病学进展(Chin J Pathophysiol),2001,22(3):143-146.
  • 3戴德哉(Dai DZ) 胡慧娟(Hu HJ) 杨平(Yang P) 等.离子通道病变与心肌重构的致心律失常性[J].中国病理生理学杂志(Chin J Pathophysiol),2000,16(10):945-947.
  • 4Yanagisawa M,Kurihara H,Kimura S,et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J].Nature,1988,31(6163):411-415.
  • 5Fang FZ,Wang ZZ,Wang SK,et al.Effect of drug on mRNA expression of voltage-gated potassium channels in myocardial remodeling by chronic L-thyroxin administration in rats[J].Drug Develop Res,2002,55(4):13-19.
  • 6Miyuachi T,Goto K.Heart failure and endothelin receptor antagonists[J].TIPS,1999,20(5):210-217.
  • 7Clozel M,Breu V,Gray GA,et al.Pharmacological characterization of Bosentan,a new potent orally active nonpeptide endothelin receptor antagonist[J].J Pharmacol Exp Ther,1994,270(1):228-235.
  • 8Boffa JJ,Tharaux PL,Dussaule JC,et al.Regression of renal vascular fibrosis by endothelin receptor antagonism[J].Hypertension ,2001,37(Part 2):490-496.
  • 9Ellahham SH,Charlon V,Abassi Z,et al.Bosentan and the endothelin system in congestive heart failure[J].Clin Cardiol,2000,23(11):803-807.
  • 10Sam F,Colucci WS.Role of endothelin-1 in myocardial failure[J].Proc Assoc Am Physicians,1999,111(5):417-422.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部